MODEYSO

This brand name is authorized in United States.

Active ingredients

The drug MODEYSO contains one active pharmaceutical ingredient (API):

`1`	Dordaviprone UNII `53VG71J90J` - DORDAVIPRONE DIHYDROCHLORIDE
	Dordaviprone is a protease activator of the mitochondrial caseinolytic protease P (ClpP). Dordaviprone also inhibits the dopamine D2 receptor. Dordaviprone exhibited antitumor activity in cell-based assays and in vivo models of H3 K27M-mutant diffuse glioma.
	Read more about Dordaviprone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MODEYSO Capsule	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	68727-250

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.